nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Contents
|
|
|
2004 |
31 |
2 |
p. v-ix nvt p. |
artikel |
2 |
Forthcoming issues
|
|
|
2004 |
31 |
2 |
p. xii- 1 p. |
artikel |
3 |
Index
|
|
|
2004 |
31 |
2 |
p. 379-387 9 p. |
artikel |
4 |
Introduction to risk assessment and serum risk markers for the prevention of coronary heart disease and other potential conditions that impact men's health, part II: what do I tell my patients?
|
Moyad, Mark A |
|
2004 |
31 |
2 |
p. 199-205 7 p. |
artikel |
5 |
Introduction to risk assessment and serum risk markers for the prevention of coronary heart disease and other potential conditions that impact men's health, part I: what do I tell my patients?
|
Moyad, Mark A. |
|
2004 |
31 |
2 |
p. 195-198 4 p. |
artikel |
6 |
Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention?
|
Moyad, Mark A |
|
2004 |
31 |
2 |
p. 301-311 11 p. |
artikel |
7 |
Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention?
|
Moyad, Mark A. |
|
2004 |
31 |
2 |
p. 289-300 12 p. |
artikel |
8 |
Potential pathologic markers for prostate chemoprevention studies
|
Sakr, Wael A |
|
2004 |
31 |
2 |
p. 227-235 9 p. |
artikel |
9 |
Preventing male osteoporosis: prevalence, risks, diagnosis and imaging tests
|
Moyad, Mark A |
|
2004 |
31 |
2 |
p. 321-330 10 p. |
artikel |
10 |
Prevention and management of prostate cancer chemotherapy complications
|
Beer, Tomasz M |
|
2004 |
31 |
2 |
p. 367-378 12 p. |
artikel |
11 |
Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part I
|
Moyad, Mark A |
|
2004 |
31 |
2 |
p. 249-257 9 p. |
artikel |
12 |
Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part II
|
Moyad, Mark A |
|
2004 |
31 |
2 |
p. 259-273 15 p. |
artikel |
13 |
Preventive medicine and men's health
|
Moyad, Mark A. |
|
2004 |
31 |
2 |
p. xiii-xiv nvt p. |
artikel |
14 |
Prostate cancer and coronary heart disease: correlation or coincidence?
|
Moyad, Mark A |
|
2004 |
31 |
2 |
p. 207-212 6 p. |
artikel |
15 |
Reducing the toxicity associated with the use of radiotherapy in men with localized prostate cancer
|
Roach III, Mack |
|
2004 |
31 |
2 |
p. 353-366 14 p. |
artikel |
16 |
Risk factors for adult renal cell carcinoma
|
Dhote, R |
|
2004 |
31 |
2 |
p. 237-247 11 p. |
artikel |
17 |
Screening for prostate cancer: current recommendations
|
Wilson, Shandra S. |
|
2004 |
31 |
2 |
p. 219-226 8 p. |
artikel |
18 |
The impact of obesity in urology
|
Mydlo, Jack H |
|
2004 |
31 |
2 |
p. 275-287 13 p. |
artikel |
19 |
The impact of osteoporosis in men treated for prostate cancer
|
Oefelein, Michael G |
|
2004 |
31 |
2 |
p. 313-319 7 p. |
artikel |
20 |
The potential role of cyclooxygenase-2 inhibitors and 5α-reductase inhibitors in the prevention of urologic conditions
|
Hernandez, Javier |
|
2004 |
31 |
2 |
p. 213-218 6 p. |
artikel |
21 |
Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician
|
Higano, Celestia S |
|
2004 |
31 |
2 |
p. 331-352 22 p. |
artikel |